Detection and serial monitoring of cells expressing the epithelial surface molecule EpCAM in peripheral blood of patients with hormone receptor positive breast cancer was used to follow the fate of these cells during endocrine e treatment. This evidence concerns the gene NR4A1 and breast carcinoma.